Mettez-vous hors ligne avec l'application Player FM !
Exploring the Intersection of Intellectual Property and Biotech Innovation
Manage episode 440605014 series 2401268
In the latest episode of the Vital Health podcast, we engage in a thought-provoking discussion with Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Innovation Organization (BIO), and Gwen O'Loughlin, a seasoned health data researcher. Together, they unpack the complexities of intellectual property (IP) in the rapidly evolving biotech landscape.
Hans and Gwen share insights into the current challenges facing the industry, particularly in the wake of new patent eligibility standards. "The crux of innovation in biotech is not just discovery, but ensuring those discoveries are protected and can reach the market," says Sauer, emphasizing the critical role of IP in fostering continued advancement.
The conversation also touches on the impact of recent court rulings on biotech patents and what these changes mean for future innovation. Gwen adds, "Understanding these legal nuances is key for anyone in biotech—it’s about protecting your work and driving the industry forward."
This episode is a must-listen for anyone involved in biotech, law, or IP management, offering a deep dive into how legal frameworks shape the future of biotechnology.
See omnystudio.com/listener for privacy information.
101 episodes
Manage episode 440605014 series 2401268
In the latest episode of the Vital Health podcast, we engage in a thought-provoking discussion with Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Innovation Organization (BIO), and Gwen O'Loughlin, a seasoned health data researcher. Together, they unpack the complexities of intellectual property (IP) in the rapidly evolving biotech landscape.
Hans and Gwen share insights into the current challenges facing the industry, particularly in the wake of new patent eligibility standards. "The crux of innovation in biotech is not just discovery, but ensuring those discoveries are protected and can reach the market," says Sauer, emphasizing the critical role of IP in fostering continued advancement.
The conversation also touches on the impact of recent court rulings on biotech patents and what these changes mean for future innovation. Gwen adds, "Understanding these legal nuances is key for anyone in biotech—it’s about protecting your work and driving the industry forward."
This episode is a must-listen for anyone involved in biotech, law, or IP management, offering a deep dive into how legal frameworks shape the future of biotechnology.
See omnystudio.com/listener for privacy information.
101 episodes
Tous les épisodes
×1 Breaking Barriers: The Prime Rose Project and Off-Label Drug Innovations 29:15
1 Impact of the Inflation Reduction Act on Venture Capital in Life Sciences 36:11
1 Investing in Health: Pathways to a Well-being Economy and Smarter Healthcare Budgets 35:30
1 Addressing Europe's Health Challenges: Innovation, Prevention, and Policy 38:30
1 The Future of Biotech: Steve Potts on Innovation, Policy, and the Impact of the IRA 24:58
1 Revolutionizing Healthcare with Real-World Data 27:13
1 Exploring the Intersection of Intellectual Property and Biotech Innovation 56:52
1 Unlocking the Power of Genomic Data: NashBIO's Role in Healthcare Innovation 19:00
1 MEP Pernille Weiss – Rapporteur of the EU GPL 47:33
1 Transforming Health Communications: Insights from Virginia Amann 26:51
1 Joe Panetta – Policy Impacts on California Biopharma 27:30
1 Niklas Blomberg, Executive Director, EU Innovative Health Initiative 19:58
1 Congressman Michael Burgess – IRA and March-in Rights 28:55
1 Kim Hawkins - Project Co-Lead of IMI’s Trials@Home 32:51
1 Douglas Holtz-Eakin, “Indications are going to be deeply affected by the IRA” 54:59
Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.